| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 2 |
| 1 | BOSENTAN | 2 |
| 2 | SELEXIPAG | 2 |
| 3 | TADALAFIL | 2 |
| 4 | TREPROSTINIL | 2 |
| 5 | ABALOPARATIDE | 1 |
| 6 | AGALSIDASE BETA | 1 |
| 7 | ALPRAZOLAM | 1 |
| 8 | ARMODAFINIL | 1 |
| 9 | BENDAMUSTINE HCL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARGLUMIC ACID | 1 | 0.0013 |
| 1 | EFGARTIGIMOD ALFA | 1 | 0.0003 |
| 2 | RIPRETINIB | 1 | 0.0002 |
| 3 | VILAZODONE HYDROCHLORIDE | 1 | 0.0001 |
| 4 | AGALSIDASE BETA | 1 | 0.0001 |
| 5 | SELEXIPAG | 2 | 0.0001 |
| 6 | ROPINIROLE | 1 | 0.0001 |
| 7 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 8 | ARMODAFINIL | 1 | 0.0000 |
| 9 | ETONOGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 1 | 0.0013 |
| 1 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 4 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 5 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 6 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Endothelin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Prostacycline Vasodilator [EPC] | 2 | 0.0000 |